Clinlab India 2024 Conference – Industry Update

MEDICAL FAIR INDIA is India’s leading Trade Fair for the Medical and Healthcare Industry. For the last 28 years, Medical Fair India has been successfully addressing the various needs of Hospitals, Health Centres & Clinics.  With participation from over 20 countries, MEDICAL FAIR INDIA provides an opportunity to position your brand among competitors and further increase your level of visibility. MEDICAL FAIR INDIA acts as a platform where connections are made and business relationships are nurtured.

ClinLab India is the exhibition & conference on the topic of laboratory medicine, Point of Care Testing, molecular diagnostics and clinical chemistry. The show is aimed to promote the recent developments and market trends in the in-vitro diagnostics (IVD) sector and allied areas.

ClinLab India brings together the leaders in the medical laboratory industry designed to create maximum interaction and meeting opportunities where manufacturers, dealers and distributors can promote their brands, meet potential customers and entertain existing clients. 

The year 2024 holds a lot of promise for the Indian IVD industry. Technology is also going to be a critical growth factor. The Indian start-up ecosystem is aggressively targeting the IVD-MedTech segment, and we will see some compelling solutions from them soon

This is the 5th Edition of ClinLab India.

Conference Theme 2024 :
Driving Global Dominance through Innovations :
– IVD Industry’s Role in Economic Growth

𝗪𝗵𝗲𝗻 ?
📅 Date: 14th March 2024 – Thursday
⏲ Time: 10 00 am – 5 00 pm
🌆 Venue: Bombay Exhibition Centre, Mumbai

𝗪𝗵𝗼 𝗦𝗵𝗼𝘂𝗹𝗱 𝗔𝘁𝘁𝗲𝗻𝗱 ?

IVD , Biotech companies – Management & Technical Personnel, Healthcare Services – Management & Technical Teams from Clinical Labs/Hospitals/Blood Banks/CROs/Medical Colleges/Home Healthcare Companies and Other Healthcare Organisations , Startups, Innovators from Biotech space, Other stakeholders, Government Representatives

𝐅𝐨𝐫 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐬, please visit :

https://www.medicalfair-india.com/special-shows-clin-lab-india

Conference Entry by Prior Registration.

Delegate Fee : INR 1100 per participant (including GST). Fee includes Lunch & Hi Tea

𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 :

𝗦𝘁𝗲𝗽 𝟭 :

Make the payment using the QR code shared below

Step 2:
Click the ‘Register here” button given below and fill up the delegate registration form. Please mention the payment reference number in the form 

For more information about Expo, visit : https://www.medicalfair-india.com

For enquiries related to Conference Partnerships, Stalls booking inside Diagnostics Pavilion , delegate registration enquiries, pls write to :

VermaA@md-india.com +91-124-4544507
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

For conference delegate registration enquiries, please write to :
Ms Rama Venugopal – info@events.healthcare / +91 9840870532

Source: https://events.healthcare/

Regulatory Awareness & Experiential Learning Workshop

Indian Council of Medical Research (ICMR)is conducting a Regulatory Awareness & Experiential Learning Workshop for Medical Device/Diagnostic Innovators/Start-ups in India jointly with Central Drugs Standard Control Organisation (CDSCO) on 12th Oct 2023 at ICMR Hqrs, New Delhi.

Date of the Workshop – 12th October 2023
Time – 10 am to 5 pm
Venue – Conference Hall, ICMR Hqrs, New Delhi
Mode of workshop – Hybrid mode

Last Date for Registration – 30th September 2023

Registration Link – https://docs.google.com/forms/d/e/1FAIpQLSeQZCq00-CnvqpG-tUZRHF43fc3gthxkGvVSl-3KP9FrmKyqw/viewform

Cybersecurity in Medical Devices

FDA requires medical devices be secured against cyberattacks

Medical devices are increasingly connected to the Internet, hospital networks, and other medical devices to provide features that improve health care and increase the ability of health care providers to treat patients. These same features also increase potential cybersecurity risks. Medical devices, like other computer systems, can be vulnerable to security breaches, potentially impacting the safety and effectiveness of the device.

Under FDA guidance issued this week, all new medical device applicants must now submit a plan on how to “monitor, identify, and address” cybersecurity issues, as well as create a process that provides “reasonable assurance” that the device in question is protected.

Applicants will also need to make security updates and patches available on a regular schedule and in critical situations, and provide the FDA with “a software bill of materials,” including any open-source or other software their devices use.

As part of the new law, the FDA must also update its medical device cybersecurity guidance at least every two years.

Source: https://www.fda.gov/medical-devices/digital-health-center-excellence/cybersecurity

Health Ministry to rope in State Governments to establish Medical Devices Testing Laboratories

Health Ministry to rope in State Governments to establish Medical Devices Testing Laboratories

The Ministry of Health and Family Welfare (MoHFW) is planning to rope in state governments also to establish or designate their existing laboratories as state medical devices testing laboratories and bring in enabling rules to support setting up of more testing laboratories for medical devices across the country as the sector is experiencing major regulatory paradigm shift including the introduction of a licensing regime.

A draft rule has been notified by the Ministry, under which it has proposed to insert a new sub-rule to the Rule 19, that the state government may, by notification, establish state medical devices testing laboratory for the purpose of testing and evaluation of medical devices or to carry out any other functions as may be specifically assigned to it.

The State Government may also designate any laboratory having facility for carrying out and evaluation of medical devices as state medical devices testing laboratory for the purpose, with a condition that the laboratory should be accredited by the National Accreditation Body for Testing and Calibration Laboratories (NABL).

It has also added a definition to the state medical devices testing laboratory, stating that it means a laboratory established or designated by the state government under the Rule 19(3), which is the freshly proposed sub-rule. While the Rule 19 was specifically for Central medical devices testing laboratory, it has been proposed for amendment by omitting the word ‘Centre’, this emphasising that the laboratories could be established either by the Central or the state government. The draft amendment is expected to be taken into consideration in seven days from the date of making the draft available to the public.

Source: http://www.pharmabiz.com/NewsDetails.aspx?aid=156725&sid=1